ANATOMY-FOUND · Novel Imaging of the heart for new structural and metabolic diagnosis
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2017-02-01 → 2019-01-31
- Финансиране от ЕС
- 200 195 €
- Участници
- 1
- Схема
- MSCA-IF-EF-ST
Линиите свързват координатора с партньорите.
Накратко на български
Микроанатомията и метаболизмът на сърцето се изследват чрез 3D и 4D изображения, за да се разбере как работят клетките и проводящата система. Това помага за по-ранна и точна диагностика на сърдечно-съдовите заболявания, които често остават неразпознати.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Novel Imaging of the heart for new structural and metabolic diagnosis
What are the overall objectives? Each year cardiovascular disease (CVD) causes over 4 mio deaths in Europe. Predictions suggest that 80% of premature heart disease and stroke is preventable, but ~20% of CVDs are misdiagnosed, and in elderly patients up to 60% of CVDs remain undiagnosed. We need to develop new technologies and strategies for early and accurate diagnosis of the biggest killer in western society. Early CVD processes begin in heart cells, before evolving to the ’macro’ pathology recognisable by traditional techniques. Clinicians desire a non-invasive technique that can provide high-resolution micro-anatomy in 3-dimensions, and organ specific regional metabolic assessment. However the intricate micro-anatomy of the heart and its dynamic relationship with cardiac function is still fiercely debated. We set out to investigate the following questions: 1) what is the true micro-anatomy of the heart, and how is it remodelled in disease? 2) What is the role of 3-dimensional micro-anatomy in 4-dimensional pump function? 3) Does micro-anatomical remodelling correlate with regional changes in metabolism? Using state-of-the-art non-invasive 3d and 4d ex-vivo and in-vivo imaging methodologies, we attempted to answer these questions. In this regard, we have provided novel information regarding the 3D disposition of the cardiac conduction system in normal and congenitally malformed human hearts. We have shed light on the true micro-anatomy of the working myocardium, challenging traditional views, and providing new insight into how the micro-structure of the heart facilitates contraction and is modified in disease. We also confirmed the efficacy of in-vivo metabolic imaging for the assessment of metabolic impairment in heart failure. With initial results suggesting micro-anatomical remodelling does accompany regional metabolic remodelling. We now have an improved understanding of the micro-anatomy of the heart in 3-dimensions and its relationship with contraction and metabolism in disease. We hope that our findings and on-going research will aid in detecting and correlating novel morphological and metabolic changes upstream of the macro-anatomical and non-specific metabolic changes, providing the foundation for a step-wise change in diagnosis of CVD.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Each year cardiovascular disease (CVD) causes over 4 million deaths in Europe. Predictions suggest that 80% of premature heart disease and stroke is preventable, but ~20% of CVDs are misdiagnosed, and in elderly patients up to 60% of CVDs remain undiagnosed. We need to develop new technologies and strategies for early and accurate diagnosis of the biggest killer in western society.Currently, diagnosis of CVD is based on assessment of macro-anatomy, whole heart function, and whole body metabolic markers. Early CVD processes begin in heart cells, before evolving to the ’macro’ pathology recognisable by traditional techniques. Clinicians desire a non-invasive technique that can provide high-resolution 3D micro-anatomy, and organ specific regional metabolic assessment. However the intricate micro-anatomy of the heart and its dynamic relationship with cardiac function is still fiercely debated.To elucidate the true micro-anatomy of the heart, and understand its correlation with both pump- and metabolic function in health and disease, I will investigate the following questions:1)What is the true micro-anatomy of the heart, and how is it remodelled in disease?2)What is the role of 3D micro-anatomy in 4D pump function?3)Does micro-anatomical remodelling correlate with regional changes in metabolism?Using novel state-of-the-art non-invasive 3D and 4D ex-vivo and in-vivo imaging methodologies, I will answer these questions. We will finally understand the micro-anatomy of the heart in 3D, and its relationship with cardiac contraction and metabolism in disease. I hypothesise detecting and correlating novel morphological and metabolic changes upstream of the macro-anatomical and non-specific metabolic changes identifiable by traditional techniques, will offer the foundation for a step-wise change in diagnosis of CVD.Working with world-renowned researchers, I will develop interdisciplinary skills in functional cardiac imaging to support a productive career in academia.
Оригинален текст от CORDIS (на английски).
Участници
- AARHUS UNIVERSITET · Aarhus CКоординаторДания
Връзки
Данни: CORDIS, © Европейски съюз
